Enjoy the crispy and golden goodness of Mushabak Halabi, a traditional Middle Eastern churro style dessert soaked in sweet ...

Dry brown sand is slowly scraped across a rough surface, creating a deep, gritty ASMR texture that feels grounding and raw. Each steady stroke produces a soothing cascade of earthy sounds, blending ...

NEW ORLEANS, LA—Adding the factor XIa inhibitor asundexian (Bayer) to antiplatelet therapy tops antiplatelet therapy alone for preventing ischemic strokes in patients with acute noncardioembolic ...

Transient Ischemic Attack, also known as "mini-stroke", occurs when there is a temporary blockage of blood flow to the brain. The American Stroke Association says that the clot usually dissolves on ...

Please provide your email address to receive an email when new articles are posted on . Societies issued new guidelines for the screening and treatment of stroke. The new document provides ...

As stroke risk rises for women as they age — especially after menopause — a new long-term study suggests that what they eat may play a powerful role in lowering that risk. Stroke is a leading cause of ...

This is read by an automated voice. Please report any issues or inconsistencies here. ASMR, or autonomous sensory meridian response, is the calming tingling sensation brought on by gentle auditory, ...

“This update brings the most important advances in stroke care from the last decade directly into practice,” Shyam Prabhakaran, MD, chair of the writing group, said in a statement. “New ...

Deaths from both causes are down, but they still eclipse all other causes, according to new statistics. By Nina Agrawal Despite gains in treatment, cardiovascular disease remains the leading cause of ...

The authors do not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and have disclosed no relevant affiliations beyond their ...

Asundexian reduced ischemic stroke risk without increasing major bleeding in the OCEANIC-STROKE study, meeting primary efficacy and safety endpoints. The study included 12,327 patients with acute ...

Asundexian (Bayer) significantly reduces the risk of ischemic stroke compared with placebo, without increasing the risk of major bleeding, when used for secondary stroke prevention in patients treated ...